Buy BeyondSpring Stock | BYSI Stock Price & Latest News | Public
BYSI

BeyondSpring

$0.00 (0.00%)Today

    About BYSI

    BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company's lead asset is the Plinabulin that is in late stage clinical trials as an anti-cancer agent in combination w...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.39
    -0.58
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.54

    Actual EPS
    Q3 2020

    Stats

    Market Cap$395,74M
    Volume8,59k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$21.50
    1 Year Low$9.38
    Open$12.77
    High$13.42
    Low$12.62

    Buy any stock with any amount of money.

    Download the App
    Download the app